Aug 2026
Particle size-dependent efficiency and mechanistic insights of nose-to-brain delivery bypassing the BBB.
Central nervous system (CNS) diseases remain a therapeutic challenge due to the blood-brain barrier (BBB). The nose-to-brain pathway offers a promising non-invasive route to bypass the BBB, yet the impact of nanocarrier size on this multi-stage delivery process is poorly understood. This study systematically investigat...
Chunfu Wei, Jing Zhang, Guanlin Wang et al.
· Journal of Controlled Releas... · 0 citations